Graviton Bioscience
Justin Stebbing is currently serving in various roles across multiple companies in the healthcare and biotechnology industry, including positions such as Senior VP Clinical Strategy and Innovation, Scientific Advisor, Board Member, Consultant Oncologist, and Chair of Scientific Advisory Boards. Justin is also involved in academic institutions as a Visiting Professor and Professor of Biomedical Sciences. With a diverse educational background in medicine and immunology from esteemed universities like the University of Oxford and The Johns Hopkins University, Justin is a highly experienced and knowledgeable professional in the field.
This person is not in any offices
Graviton Bioscience
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.